FDA.reportPublic FDA data

Exforge HCT 5/160/25 Oral Tablet

RxCUI
848149
RxNorm name
Exforge HCT 5/160/25 Oral Tablet
Display name
Exforge HCT 5/160/25 Oral Tablet
Full name
Exforge HCT 5/160/25 Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:48

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Exforge HCTAMLODIPINE VALSARTAN AND HYDROCHLOROTHIAZIDENovartis Pharmaceuticals Corporation18d7820d-471f-4ee2-9ec6-25d8d27c77de2025-12-12Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 848149

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
18d7820d-471f-4ee2-9ec6-25d8d27c77deEXFORGE HCT 5 MG / 160 MG / 25 MG Oral Tablet [PSN] · amlodipine 5 MG / hydrochlorothiazide 25 MG / valsartan 160 MG Oral Tablet [Exforge HCT] [SBD] · Amlodipine 5 MG / HCTZ 25 MG / valsartan 160 MG Oral Tablet [Exforge HCT] [SY] · Exforge HCT 5/160/25 (amlodipine / valsartan / HCTZ) Oral Tablet [SY] · Exforge HCT 5/160/25 Oral Tablet [SY]533These highlights do not include all the information needed to use EXFORGE HCT safely and effectively. See full prescribing information for EXFORGE HCT. EXFORGE HCT ® (amlodipine, valsartan, and hydrochlorothiazide) tablets, for oral use Initial U.S. Approval: 200920251212